Brief: India's Wanbury expects no material impact from Thane FDA notice
08/11/2016 14:11
Nov 8 (Reuters) - Wanbury Ltd WANB.NS
* India's Wanbury says show cause notice from Thane FDA does
not have material impact on operations
Further company coverage: WANB.NS
Recent news on Wanbury
See all newsBrief: Wanbury Says Tanuku API Site Completes TGA Quality Inspection
Brief: Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients
Brief: Wanbury Says Patalganga Site Has Completed Korea FDA Regulatory Inspection Successfully
Brief: Wanbury Ltd Launches Coriminic CPM Drops For Pediatric Use
Brief: Wanbury Receives Sertraline Form II Approval From Anvisa, Brazil